Monte Carlo Simulation (MCS) to Estimate In Vitro Susceptibility Breakpoints (BPs) for Moxifloxacin (M), Gatifloxacin (G) and Levofloxacin (L) against Staphylococcus aureus (SA)
Monte Carlo Simulation (MCS) to Estimate In Vitro Susceptibility Breakpoints (BPs) for Moxifloxacin (M), Gatifloxacin (G) and Levofloxacin (L) against Staphylococcus aureus (SA), Lead author: Meagher A, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC
